Best Medical Oncologists for Targeted Therapy in Bengaluru, India

This page lists 4 targeted therapy doctors in Bengaluru, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 4 targeted therapy doctors in Bengaluru, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Targeted Therapy doctors in Bengaluru, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Targeted Therapy doctors

Image not available Featured

Dr. Kirankumar Sajjanshetty

MBBS, MD (Radiotherapy), DM (Medical Oncology), ECMO (Medical Oncology)
Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Hospitals Bengaluru, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Medical Oncologist
  • Consultant — Medical Oncology at Gleneagles Hospitals, Bengaluru, Present
Expertise & Procedures
  • Chemotherapy Administration and Infusion Management
  • Cancer Immunotherapy and Checkpoint Inhibitor Therapy
  • Molecular Targeted Therapy Planning
  • Hormone Therapy for Breast and Gynaecologic Cancers
  • Hematologic Malignancy Management
View all procedures →
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Gleneagles Hospitals
Image not available

Dr. Sireesh Kumar Ch

DNB, MD
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India4+ Years experience
Why consider this doctor?
  • 4+ years of experience in Medical Oncologist
  • Consultant Medical Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, Present
  • Medical Oncology Training — Aster MIMS, Calicut
Expertise & Procedures
  • Chemotherapy Administration
  • Immunotherapy and Checkpoint Inhibitors
  • Molecular Targeted Therapy
  • Hormone Therapy Management
  • Palliative Cancer Care
View all procedures →
Medical Oncologist Experience: 4+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Image not available

Dr. Spoorthi G Reddy

MBBS, MD, DNB
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India5+ Years experience
Why consider this doctor?
  • 5+ years of experience in Medical Oncologist
  • Associate Consultant, Medical Oncology Department, Apollo Hospitals, Bannerghatta Road, Bengaluru — Present
  • Training rotations at Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru
Expertise & Procedures
  • Adjuvant chemotherapy for solid tumors
  • Neoadjuvant chemotherapy protocols
  • Immune checkpoint inhibitor therapy
  • Molecular targeted therapy
  • Palliative chemotherapy
View all procedures →
Medical Oncologist Experience: 5+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Image not available

Dr. Vijay Agarwal

MBBS, MD, MRCP (UK), PhD, DIC, DLST(IC)
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospitals, Bannerghatta Road Bengaluru, India19+ Years experience
Why consider this doctor?
  • 19+ years of experience in Medical Oncologist
  • Consultant, Medical Oncology — Apollo Hospitals, Bannerghatta Road, Bengaluru, India (Present)
  • Senior Oncology Clinician — Specialized in multimodal cancer treatment across solid and hematologic malignancies
Expertise & Procedures
  • Chemotherapy administration for solid tumors
  • Adjuvant chemotherapy protocols
  • Neoadjuvant chemotherapy planning
  • Immunotherapy and checkpoint inhibitor therapy
  • Molecular targeted therapy
View all procedures →
Medical Oncologist Experience: 19+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH

Hospitals where these doctors practise

Apollo Hospital, Bannerghatta Road🇮🇳 Bangalore, India
Starting from$300

Apollo Hospital, Bannerghatta Road

Est. 2007
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation
Targeted TherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Targeted Therapy
4.2
25 reviews
250+
Beds
19+
Years Since Founded
Dr. Sireesh Kumar ChDr. Spoorthi G ReddyDr. Vijay Agarwal

Why consider treatment in India?

Many international patients consider India for lymphoma treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Targeted Therapy?

Targeted therapy uses drugs designed to specifically identify and attack cancer cells based on genetic mutations, proteins, or receptors, while sparing normal healthy cells. It is used across breast, lung, colorectal, gastric, liver, pancreatic, prostate, ovarian, head & neck cancers, leukemia, lymphoma, and multiple myeloma, often guided by biomarker or genomic testing. India offers internationally accredited cancer centres with access to the latest targeted agents at a fraction of Western costs.

Who may be considered?

Targeted Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

3 approaches available for this procedure:

Biomarker/Genomic Testing & Drug Selection

Essential First Step

Tumor tissue or blood samples are analyzed for specific mutations (e.g., HER2, EGFR, ALK, KRAS, BRCA) to determine eligibility for a matched targeted drug.

Comprehensive Investigations

Estimated cost: $300 - $1,500

Tumor biopsy, IHC/FISH testing, next-generation sequencing (NGS) panel, liquid biopsy, complete blood count (CBC), liver and kidney function tests

Treatment / Procedure Estimate

Estimated cost in India: $300 - $2,000

Stay in India

Pre-procedure stay (outside hospital): ~2 days
Hospitalisation: 0 days (outpatient)
Recovery period (outside hospital): ~1 day
Total stay: approx 3 days

Usually Included in Hospital Package

  • Oncologist consultation
  • Tissue/blood sample processing
  • Genomic report interpretation
  • Tumor board review

Usually Not Included

  • International shipping of external samples
  • Repeat biopsy if sample inadequate
  • Second confirmatory pathology opinion

Recovery and follow-up

Most patients tolerate targeted therapy on an outpatient or short-stay basis, with periodic monitoring for side effects such as fatigue, skin reactions, or organ toxicity; response is typically reassessed via imaging every 2-3 treatment cycles.

Risks

Potential risks include infusion reactions, cardiotoxicity, skin and gastrointestinal side effects, elevated liver enzymes, and, less commonly, resistance development requiring drug switch.

Alternatives

Depending on cancer type and stage, alternatives may include conventional chemotherapy, immunotherapy, hormonal therapy, radiation, or surgical resection, often used in combination with or instead of targeted therapy.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Histopathology and biopsy report
  • IHC/FISH biomarker results (HER2, ER/PR, etc.)
  • Next-generation sequencing (NGS) or mutation panel report
  • Recent CT/PET-CT/MRI imaging
  • Complete blood count and organ function tests
  • Prior treatment and chemotherapy history
  • Discharge summaries from previous hospitalizations
  • Current medication list

Patient information needed

  • Cancer type, stage, and site of primary tumor
  • Prior treatments including surgery, chemotherapy, radiation
  • Known genetic mutations or biomarker status if tested
  • Current performance status and comorbidities
  • Allergy history, especially to biologic drugs
  • Cardiac history if cardiotoxic drugs are anticipated
  • Insurance or budget considerations
  • Availability of a caregiver/companion during treatment

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Targeted Therapy) and procedure (Targeted Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Targeted Therapy in Bengaluru, India

What is Lymphoma?
Lymphoma is a type of blood cancer that originates in lymphocytes, the immune cells that travel through the lymphatic system. It can arise in lymph nodes, the spleen, bone marrow, or virtually any organ, and encompasses a wide spectrum of subtypes ranging from slow-growing (indolent) to highly aggressive forms.
What are the symptoms and health risks of Lymphoma?
Common signs include painless swelling of lymph nodes in the neck, armpits, or groin; persistent fatigue; unexplained weight loss; drenching night sweats; and fever — a cluster sometimes referred to clinically as 'B symptoms.' Some people also experience shortness of breath, itching, or a feeling of fullness in the abdomen if the spleen or abdominal nodes are involved. These symptoms can overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of lymphoma.
How is Lymphoma diagnosed?
Diagnosis typically begins with a clinical evaluation, blood tests (including a full blood count, LDH, and beta-2 microglobulin levels), and imaging such as CT or PET-CT scanning to assess the extent of disease. A biopsy of an affected lymph node or tissue — analysed with immunohistochemistry and, where indicated, molecular or genetic testing — is essential to confirm the specific lymphoma subtype. Staging (using systems such as the Ann Arbor or Lugano classification) and relevant prognostic indices (such as the International Prognostic Index for non-Hodgkin lymphoma) then guide treatment planning.
How is Lymphoma treated?
Treatment is highly individualised and depends on the lymphoma subtype, stage, patient age, overall health, and specific molecular features. Options range from active surveillance ('watch and wait') for certain slow-growing indolent lymphomas to chemotherapy, immunotherapy, targeted therapy, radiation therapy, or combinations of these for more aggressive or advanced disease. In eligible patients with relapsed or refractory lymphoma, high-dose chemotherapy followed by autologous stem cell transplantation — or, in selected cases, allogeneic transplantation — may offer the best chance of sustained remission.
Can Lymphoma be treated without a procedure?
The majority of lymphoma treatment is non-surgical. Indolent lymphomas that are asymptomatic and low-burden may be managed initially with active monitoring alone. When treatment is needed, chemotherapy regimens (such as R-CHOP for many B-cell lymphomas), monoclonal antibody immunotherapy, targeted small-molecule agents, and radiotherapy are the primary tools, and many patients achieve remission without any surgical intervention.
When is Targeted Therapy considered for Lymphoma?
Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Lymphoma?
Lymphoma is typically evaluated and managed by a medical oncologist or haematologist with specific expertise in lymphoid malignancies, often in close collaboration with a radiation oncologist when radiotherapy is part of the plan, and with a bone marrow transplant specialist if stem cell transplantation is being considered.
How do I choose a doctor for Lymphoma?
When selecting a care team, look for a specialist with documented experience in the specific lymphoma subtype relevant to your case, access to a multidisciplinary tumour board, and affiliation with a centre that offers the full range of therapies — including advanced options such as stem cell transplantation and clinical trials — along with structured long-term follow-up.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.